COVID-19 Impact on Global Pirfenidone Market Insights, Forecast to 2026
Pirfenidone market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pirfenidone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Pirfenidone market is segmented into
The Pirfenidone market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pirfenidone market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pirfenidone Market Share Analysis
Pirfenidone market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pirfenidone business, the date to enter into the Pirfenidone market, Pirfenidone product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Pirfenidone market is segmented into
- Tablet
- Capsule
- Other
- Mild Idiopathic Pulmonary Fibrosis
- Moderate Idiopathic Pulmonary Fibrosis
- Other
The Pirfenidone market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pirfenidone market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pirfenidone Market Share Analysis
Pirfenidone market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pirfenidone business, the date to enter into the Pirfenidone market, Pirfenidone product introduction, recent developments, etc.
The major vendors covered:
- Genentech (Roche)
- Shionogi
- GNI Group
- Beijing Continent
- Cipla
- Lupin Ltd
- Zydus Cadila
- Glenmark Pharmaceuticals
- Koye Pharmaceuticals
- MSN Laboratories
- Wockhardt
- Incepta Pharmaceuticals
- Unimed Unihealth
1 STUDY COVERAGE
1.1 Pirfenidone Product Introduction
1.2 Market Segments
1.3 Key Pirfenidone Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pirfenidone Market Size Growth Rate by Type
1.4.2 Tablet
1.4.3 Capsule
1.4.4 Other
1.5 Market by Application
1.5.1 Global Pirfenidone Market Size Growth Rate by Application
1.5.2 Mild Idiopathic Pulmonary Fibrosis
1.5.3 Moderate Idiopathic Pulmonary Fibrosis
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Pirfenidone Industry Impact
1.6.1 How the Covid-19 is Affecting the Pirfenidone Industry
1.6.1.1 Pirfenidone Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Pirfenidone Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Pirfenidone Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Pirfenidone Market Size Estimates and Forecasts
2.1.1 Global Pirfenidone Revenue 2015-2026
2.1.2 Global Pirfenidone Sales 2015-2026
2.2 Pirfenidone Market Size by Region: 2020 Versus 2026
2.2.1 Global Pirfenidone Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Pirfenidone Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL PIRFENIDONE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Pirfenidone Sales by Manufacturers
3.1.1 Pirfenidone Sales by Manufacturers (2015-2020)
3.1.2 Pirfenidone Sales Market Share by Manufacturers (2015-2020)
3.2 Pirfenidone Revenue by Manufacturers
3.2.1 Pirfenidone Revenue by Manufacturers (2015-2020)
3.2.2 Pirfenidone Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pirfenidone Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pirfenidone Revenue in 2019
3.2.5 Global Pirfenidone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Pirfenidone Price by Manufacturers
3.4 Pirfenidone Manufacturing Base Distribution, Product Types
3.4.1 Pirfenidone Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pirfenidone Product Type
3.4.3 Date of International Manufacturers Enter into Pirfenidone Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Pirfenidone Market Size by Type (2015-2020)
4.1.1 Global Pirfenidone Sales by Type (2015-2020)
4.1.2 Global Pirfenidone Revenue by Type (2015-2020)
4.1.3 Pirfenidone Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pirfenidone Market Size Forecast by Type (2021-2026)
4.2.1 Global Pirfenidone Sales Forecast by Type (2021-2026)
4.2.2 Global Pirfenidone Revenue Forecast by Type (2021-2026)
4.2.3 Pirfenidone Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pirfenidone Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Pirfenidone Market Size by Application (2015-2020)
5.1.1 Global Pirfenidone Sales by Application (2015-2020)
5.1.2 Global Pirfenidone Revenue by Application (2015-2020)
5.1.3 Pirfenidone Price by Application (2015-2020)
5.2 Pirfenidone Market Size Forecast by Application (2021-2026)
5.2.1 Global Pirfenidone Sales Forecast by Application (2021-2026)
5.2.2 Global Pirfenidone Revenue Forecast by Application (2021-2026)
5.2.3 Global Pirfenidone Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Pirfenidone by Country
6.1.1 North America Pirfenidone Sales by Country
6.1.2 North America Pirfenidone Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Pirfenidone Market Facts & Figures by Type
6.3 North America Pirfenidone Market Facts & Figures by Application
7 EUROPE
7.1 Europe Pirfenidone by Country
7.1.1 Europe Pirfenidone Sales by Country
7.1.2 Europe Pirfenidone Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pirfenidone Market Facts & Figures by Type
7.3 Europe Pirfenidone Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Pirfenidone by Region
8.1.1 Asia Pacific Pirfenidone Sales by Region
8.1.2 Asia Pacific Pirfenidone Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Pirfenidone Market Facts & Figures by Type
8.3 Asia Pacific Pirfenidone Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Pirfenidone by Country
9.1.1 Latin America Pirfenidone Sales by Country
9.1.2 Latin America Pirfenidone Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Pirfenidone Market Facts & Figures by Type
9.3 Central & South America Pirfenidone Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Pirfenidone by Country
10.1.1 Middle East and Africa Pirfenidone Sales by Country
10.1.2 Middle East and Africa Pirfenidone Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Pirfenidone Market Facts & Figures by Type
10.3 Middle East and Africa Pirfenidone Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Genentech (Roche)
11.1.1 Genentech (Roche) Corporation Information
11.1.2 Genentech (Roche) Description, Business Overview and Total Revenue
11.1.3 Genentech (Roche) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Genentech (Roche) Pirfenidone Products Offered
11.1.5 Genentech (Roche) Recent Development
11.2 Shionogi
11.2.1 Shionogi Corporation Information
11.2.2 Shionogi Description, Business Overview and Total Revenue
11.2.3 Shionogi Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Shionogi Pirfenidone Products Offered
11.2.5 Shionogi Recent Development
11.3 GNI Group
11.3.1 GNI Group Corporation Information
11.3.2 GNI Group Description, Business Overview and Total Revenue
11.3.3 GNI Group Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GNI Group Pirfenidone Products Offered
11.3.5 GNI Group Recent Development
11.4 Beijing Continent
11.4.1 Beijing Continent Corporation Information
11.4.2 Beijing Continent Description, Business Overview and Total Revenue
11.4.3 Beijing Continent Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Beijing Continent Pirfenidone Products Offered
11.4.5 Beijing Continent Recent Development
11.5 Cipla
11.5.1 Cipla Corporation Information
11.5.2 Cipla Description, Business Overview and Total Revenue
11.5.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Cipla Pirfenidone Products Offered
11.5.5 Cipla Recent Development
11.6 Lupin Ltd
11.6.1 Lupin Ltd Corporation Information
11.6.2 Lupin Ltd Description, Business Overview and Total Revenue
11.6.3 Lupin Ltd Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Lupin Ltd Pirfenidone Products Offered
11.6.5 Lupin Ltd Recent Development
11.7 Zydus Cadila
11.7.1 Zydus Cadila Corporation Information
11.7.2 Zydus Cadila Description, Business Overview and Total Revenue
11.7.3 Zydus Cadila Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Zydus Cadila Pirfenidone Products Offered
11.7.5 Zydus Cadila Recent Development
11.8 Glenmark Pharmaceuticals
11.8.1 Glenmark Pharmaceuticals Corporation Information
11.8.2 Glenmark Pharmaceuticals Description, Business Overview and Total Revenue
11.8.3 Glenmark Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Glenmark Pharmaceuticals Pirfenidone Products Offered
11.8.5 Glenmark Pharmaceuticals Recent Development
11.9 Koye Pharmaceuticals
11.9.1 Koye Pharmaceuticals Corporation Information
11.9.2 Koye Pharmaceuticals Description, Business Overview and Total Revenue
11.9.3 Koye Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Koye Pharmaceuticals Pirfenidone Products Offered
11.9.5 Koye Pharmaceuticals Recent Development
11.10 MSN Laboratories
11.10.1 MSN Laboratories Corporation Information
11.10.2 MSN Laboratories Description, Business Overview and Total Revenue
11.10.3 MSN Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.10.4 MSN Laboratories Pirfenidone Products Offered
11.10.5 MSN Laboratories Recent Development
11.1 Genentech (Roche)
11.1.1 Genentech (Roche) Corporation Information
11.1.2 Genentech (Roche) Description, Business Overview and Total Revenue
11.1.3 Genentech (Roche) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Genentech (Roche) Pirfenidone Products Offered
11.1.5 Genentech (Roche) Recent Development
11.12 Incepta Pharmaceuticals
11.12.1 Incepta Pharmaceuticals Corporation Information
11.12.2 Incepta Pharmaceuticals Description, Business Overview and Total Revenue
11.12.3 Incepta Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Incepta Pharmaceuticals Products Offered
11.12.5 Incepta Pharmaceuticals Recent Development
11.13 Unimed Unihealth
11.13.1 Unimed Unihealth Corporation Information
11.13.2 Unimed Unihealth Description, Business Overview and Total Revenue
11.13.3 Unimed Unihealth Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Unimed Unihealth Products Offered
11.13.5 Unimed Unihealth Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Pirfenidone Market Estimates and Projections by Region
12.1.1 Global Pirfenidone Sales Forecast by Regions 2021-2026
12.1.2 Global Pirfenidone Revenue Forecast by Regions 2021-2026
12.2 North America Pirfenidone Market Size Forecast (2021-2026)
12.2.1 North America: Pirfenidone Sales Forecast (2021-2026)
12.2.2 North America: Pirfenidone Revenue Forecast (2021-2026)
12.2.3 North America: Pirfenidone Market Size Forecast by Country (2021-2026)
12.3 Europe Pirfenidone Market Size Forecast (2021-2026)
12.3.1 Europe: Pirfenidone Sales Forecast (2021-2026)
12.3.2 Europe: Pirfenidone Revenue Forecast (2021-2026)
12.3.3 Europe: Pirfenidone Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Pirfenidone Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Pirfenidone Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Pirfenidone Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Pirfenidone Market Size Forecast by Region (2021-2026)
12.5 Latin America Pirfenidone Market Size Forecast (2021-2026)
12.5.1 Latin America: Pirfenidone Sales Forecast (2021-2026)
12.5.2 Latin America: Pirfenidone Revenue Forecast (2021-2026)
12.5.3 Latin America: Pirfenidone Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Pirfenidone Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Pirfenidone Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Pirfenidone Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Pirfenidone Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Pirfenidone Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Pirfenidone Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Pirfenidone Product Introduction
1.2 Market Segments
1.3 Key Pirfenidone Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pirfenidone Market Size Growth Rate by Type
1.4.2 Tablet
1.4.3 Capsule
1.4.4 Other
1.5 Market by Application
1.5.1 Global Pirfenidone Market Size Growth Rate by Application
1.5.2 Mild Idiopathic Pulmonary Fibrosis
1.5.3 Moderate Idiopathic Pulmonary Fibrosis
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Pirfenidone Industry Impact
1.6.1 How the Covid-19 is Affecting the Pirfenidone Industry
1.6.1.1 Pirfenidone Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Pirfenidone Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Pirfenidone Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Pirfenidone Market Size Estimates and Forecasts
2.1.1 Global Pirfenidone Revenue 2015-2026
2.1.2 Global Pirfenidone Sales 2015-2026
2.2 Pirfenidone Market Size by Region: 2020 Versus 2026
2.2.1 Global Pirfenidone Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Pirfenidone Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL PIRFENIDONE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Pirfenidone Sales by Manufacturers
3.1.1 Pirfenidone Sales by Manufacturers (2015-2020)
3.1.2 Pirfenidone Sales Market Share by Manufacturers (2015-2020)
3.2 Pirfenidone Revenue by Manufacturers
3.2.1 Pirfenidone Revenue by Manufacturers (2015-2020)
3.2.2 Pirfenidone Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pirfenidone Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pirfenidone Revenue in 2019
3.2.5 Global Pirfenidone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Pirfenidone Price by Manufacturers
3.4 Pirfenidone Manufacturing Base Distribution, Product Types
3.4.1 Pirfenidone Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pirfenidone Product Type
3.4.3 Date of International Manufacturers Enter into Pirfenidone Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Pirfenidone Market Size by Type (2015-2020)
4.1.1 Global Pirfenidone Sales by Type (2015-2020)
4.1.2 Global Pirfenidone Revenue by Type (2015-2020)
4.1.3 Pirfenidone Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pirfenidone Market Size Forecast by Type (2021-2026)
4.2.1 Global Pirfenidone Sales Forecast by Type (2021-2026)
4.2.2 Global Pirfenidone Revenue Forecast by Type (2021-2026)
4.2.3 Pirfenidone Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pirfenidone Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Pirfenidone Market Size by Application (2015-2020)
5.1.1 Global Pirfenidone Sales by Application (2015-2020)
5.1.2 Global Pirfenidone Revenue by Application (2015-2020)
5.1.3 Pirfenidone Price by Application (2015-2020)
5.2 Pirfenidone Market Size Forecast by Application (2021-2026)
5.2.1 Global Pirfenidone Sales Forecast by Application (2021-2026)
5.2.2 Global Pirfenidone Revenue Forecast by Application (2021-2026)
5.2.3 Global Pirfenidone Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Pirfenidone by Country
6.1.1 North America Pirfenidone Sales by Country
6.1.2 North America Pirfenidone Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Pirfenidone Market Facts & Figures by Type
6.3 North America Pirfenidone Market Facts & Figures by Application
7 EUROPE
7.1 Europe Pirfenidone by Country
7.1.1 Europe Pirfenidone Sales by Country
7.1.2 Europe Pirfenidone Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pirfenidone Market Facts & Figures by Type
7.3 Europe Pirfenidone Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Pirfenidone by Region
8.1.1 Asia Pacific Pirfenidone Sales by Region
8.1.2 Asia Pacific Pirfenidone Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Pirfenidone Market Facts & Figures by Type
8.3 Asia Pacific Pirfenidone Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Pirfenidone by Country
9.1.1 Latin America Pirfenidone Sales by Country
9.1.2 Latin America Pirfenidone Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Pirfenidone Market Facts & Figures by Type
9.3 Central & South America Pirfenidone Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Pirfenidone by Country
10.1.1 Middle East and Africa Pirfenidone Sales by Country
10.1.2 Middle East and Africa Pirfenidone Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Pirfenidone Market Facts & Figures by Type
10.3 Middle East and Africa Pirfenidone Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Genentech (Roche)
11.1.1 Genentech (Roche) Corporation Information
11.1.2 Genentech (Roche) Description, Business Overview and Total Revenue
11.1.3 Genentech (Roche) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Genentech (Roche) Pirfenidone Products Offered
11.1.5 Genentech (Roche) Recent Development
11.2 Shionogi
11.2.1 Shionogi Corporation Information
11.2.2 Shionogi Description, Business Overview and Total Revenue
11.2.3 Shionogi Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Shionogi Pirfenidone Products Offered
11.2.5 Shionogi Recent Development
11.3 GNI Group
11.3.1 GNI Group Corporation Information
11.3.2 GNI Group Description, Business Overview and Total Revenue
11.3.3 GNI Group Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GNI Group Pirfenidone Products Offered
11.3.5 GNI Group Recent Development
11.4 Beijing Continent
11.4.1 Beijing Continent Corporation Information
11.4.2 Beijing Continent Description, Business Overview and Total Revenue
11.4.3 Beijing Continent Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Beijing Continent Pirfenidone Products Offered
11.4.5 Beijing Continent Recent Development
11.5 Cipla
11.5.1 Cipla Corporation Information
11.5.2 Cipla Description, Business Overview and Total Revenue
11.5.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Cipla Pirfenidone Products Offered
11.5.5 Cipla Recent Development
11.6 Lupin Ltd
11.6.1 Lupin Ltd Corporation Information
11.6.2 Lupin Ltd Description, Business Overview and Total Revenue
11.6.3 Lupin Ltd Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Lupin Ltd Pirfenidone Products Offered
11.6.5 Lupin Ltd Recent Development
11.7 Zydus Cadila
11.7.1 Zydus Cadila Corporation Information
11.7.2 Zydus Cadila Description, Business Overview and Total Revenue
11.7.3 Zydus Cadila Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Zydus Cadila Pirfenidone Products Offered
11.7.5 Zydus Cadila Recent Development
11.8 Glenmark Pharmaceuticals
11.8.1 Glenmark Pharmaceuticals Corporation Information
11.8.2 Glenmark Pharmaceuticals Description, Business Overview and Total Revenue
11.8.3 Glenmark Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Glenmark Pharmaceuticals Pirfenidone Products Offered
11.8.5 Glenmark Pharmaceuticals Recent Development
11.9 Koye Pharmaceuticals
11.9.1 Koye Pharmaceuticals Corporation Information
11.9.2 Koye Pharmaceuticals Description, Business Overview and Total Revenue
11.9.3 Koye Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Koye Pharmaceuticals Pirfenidone Products Offered
11.9.5 Koye Pharmaceuticals Recent Development
11.10 MSN Laboratories
11.10.1 MSN Laboratories Corporation Information
11.10.2 MSN Laboratories Description, Business Overview and Total Revenue
11.10.3 MSN Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.10.4 MSN Laboratories Pirfenidone Products Offered
11.10.5 MSN Laboratories Recent Development
11.1 Genentech (Roche)
11.1.1 Genentech (Roche) Corporation Information
11.1.2 Genentech (Roche) Description, Business Overview and Total Revenue
11.1.3 Genentech (Roche) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Genentech (Roche) Pirfenidone Products Offered
11.1.5 Genentech (Roche) Recent Development
11.12 Incepta Pharmaceuticals
11.12.1 Incepta Pharmaceuticals Corporation Information
11.12.2 Incepta Pharmaceuticals Description, Business Overview and Total Revenue
11.12.3 Incepta Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Incepta Pharmaceuticals Products Offered
11.12.5 Incepta Pharmaceuticals Recent Development
11.13 Unimed Unihealth
11.13.1 Unimed Unihealth Corporation Information
11.13.2 Unimed Unihealth Description, Business Overview and Total Revenue
11.13.3 Unimed Unihealth Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Unimed Unihealth Products Offered
11.13.5 Unimed Unihealth Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Pirfenidone Market Estimates and Projections by Region
12.1.1 Global Pirfenidone Sales Forecast by Regions 2021-2026
12.1.2 Global Pirfenidone Revenue Forecast by Regions 2021-2026
12.2 North America Pirfenidone Market Size Forecast (2021-2026)
12.2.1 North America: Pirfenidone Sales Forecast (2021-2026)
12.2.2 North America: Pirfenidone Revenue Forecast (2021-2026)
12.2.3 North America: Pirfenidone Market Size Forecast by Country (2021-2026)
12.3 Europe Pirfenidone Market Size Forecast (2021-2026)
12.3.1 Europe: Pirfenidone Sales Forecast (2021-2026)
12.3.2 Europe: Pirfenidone Revenue Forecast (2021-2026)
12.3.3 Europe: Pirfenidone Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Pirfenidone Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Pirfenidone Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Pirfenidone Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Pirfenidone Market Size Forecast by Region (2021-2026)
12.5 Latin America Pirfenidone Market Size Forecast (2021-2026)
12.5.1 Latin America: Pirfenidone Sales Forecast (2021-2026)
12.5.2 Latin America: Pirfenidone Revenue Forecast (2021-2026)
12.5.3 Latin America: Pirfenidone Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Pirfenidone Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Pirfenidone Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Pirfenidone Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Pirfenidone Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Pirfenidone Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Pirfenidone Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Pirfenidone Market Segments
Table 2. Ranking of Global Top Pirfenidone Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pirfenidone Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Tablet
Table 5. Major Manufacturers of Capsule
Table 6. Major Manufacturers of Other
Table 7. COVID-19 Impact Global Market: (Four Pirfenidone Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Pirfenidone Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Pirfenidone Players to Combat Covid-19 Impact
Table 12. Global Pirfenidone Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 13. Global Pirfenidone Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 14. Global Pirfenidone Sales by Regions 2015-2020 (K Pcs)
Table 15. Global Pirfenidone Sales Market Share by Regions (2015-2020)
Table 16. Global Pirfenidone Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Pirfenidone Sales by Manufacturers (2015-2020) (K Pcs)
Table 18. Global Pirfenidone Sales Share by Manufacturers (2015-2020)
Table 19. Global Pirfenidone Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Pirfenidone by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pirfenidone as of 2019)
Table 21. Pirfenidone Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Pirfenidone Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Pirfenidone Price (2015-2020) (USD/Pcs)
Table 24. Pirfenidone Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Pirfenidone Product Type
Table 26. Date of International Manufacturers Enter into Pirfenidone Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Pirfenidone Sales by Type (2015-2020) (K Pcs)
Table 29. Global Pirfenidone Sales Share by Type (2015-2020)
Table 30. Global Pirfenidone Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Pirfenidone Revenue Share by Type (2015-2020)
Table 32. Pirfenidone Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 33. Global Pirfenidone Sales by Application (2015-2020) (K Pcs)
Table 34. Global Pirfenidone Sales Share by Application (2015-2020)
Table 35. North America Pirfenidone Sales by Country (2015-2020) (K Pcs)
Table 36. North America Pirfenidone Sales Market Share by Country (2015-2020)
Table 37. North America Pirfenidone Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Pirfenidone Revenue Market Share by Country (2015-2020)
Table 39. North America Pirfenidone Sales by Type (2015-2020) (K Pcs)
Table 40. North America Pirfenidone Sales Market Share by Type (2015-2020)
Table 41. North America Pirfenidone Sales by Application (2015-2020) (K Pcs)
Table 42. North America Pirfenidone Sales Market Share by Application (2015-2020)
Table 43. Europe Pirfenidone Sales by Country (2015-2020) (K Pcs)
Table 44. Europe Pirfenidone Sales Market Share by Country (2015-2020)
Table 45. Europe Pirfenidone Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Pirfenidone Revenue Market Share by Country (2015-2020)
Table 47. Europe Pirfenidone Sales by Type (2015-2020) (K Pcs)
Table 48. Europe Pirfenidone Sales Market Share by Type (2015-2020)
Table 49. Europe Pirfenidone Sales by Application (2015-2020) (K Pcs)
Table 50. Europe Pirfenidone Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Pirfenidone Sales by Region (2015-2020) (K Pcs)
Table 52. Asia Pacific Pirfenidone Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Pirfenidone Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Pirfenidone Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Pirfenidone Sales by Type (2015-2020) (K Pcs)
Table 56. Asia Pacific Pirfenidone Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Pirfenidone Sales by Application (2015-2020) (K Pcs)
Table 58. Asia Pacific Pirfenidone Sales Market Share by Application (2015-2020)
Table 59. Latin America Pirfenidone Sales by Country (2015-2020) (K Pcs)
Table 60. Latin America Pirfenidone Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Pirfenidone Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Pirfenidone Revenue Market Share by Country (2015-2020)
Table 63. Latin America Pirfenidone Sales by Type (2015-2020) (K Pcs)
Table 64. Latin America Pirfenidone Sales Market Share by Type (2015-2020)
Table 65. Latin America Pirfenidone Sales by Application (2015-2020) (K Pcs)
Table 66. Latin America Pirfenidone Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Pirfenidone Sales by Country (2015-2020) (K Pcs)
Table 68. Middle East and Africa Pirfenidone Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Pirfenidone Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Pirfenidone Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Pirfenidone Sales by Type (2015-2020) (K Pcs)
Table 72. Middle East and Africa Pirfenidone Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Pirfenidone Sales by Application (2015-2020) (K Pcs)
Table 74. Middle East and Africa Pirfenidone Sales Market Share by Application (2015-2020)
Table 75. Genentech (Roche) Corporation Information
Table 76. Genentech (Roche) Description and Major Businesses
Table 77. Genentech (Roche) Pirfenidone Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Genentech (Roche) Product
Table 79. Genentech (Roche) Recent Development
Table 80. Shionogi Corporation Information
Table 81. Shionogi Description and Major Businesses
Table 82. Shionogi Pirfenidone Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Shionogi Product
Table 84. Shionogi Recent Development
Table 85. GNI Group Corporation Information
Table 86. GNI Group Description and Major Businesses
Table 87. GNI Group Pirfenidone Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. GNI Group Product
Table 89. GNI Group Recent Development
Table 90. Beijing Continent Corporation Information
Table 91. Beijing Continent Description and Major Businesses
Table 92. Beijing Continent Pirfenidone Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Beijing Continent Product
Table 94. Beijing Continent Recent Development
Table 95. Cipla Corporation Information
Table 96. Cipla Description and Major Businesses
Table 97. Cipla Pirfenidone Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Cipla Product
Table 99. Cipla Recent Development
Table 100. Lupin Ltd Corporation Information
Table 101. Lupin Ltd Description and Major Businesses
Table 102. Lupin Ltd Pirfenidone Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Lupin Ltd Product
Table 104. Lupin Ltd Recent Development
Table 105. Zydus Cadila Corporation Information
Table 106. Zydus Cadila Description and Major Businesses
Table 107. Zydus Cadila Pirfenidone Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Zydus Cadila Product
Table 109. Zydus Cadila Recent Development
Table 110. Glenmark Pharmaceuticals Corporation Information
Table 111. Glenmark Pharmaceuticals Description and Major Businesses
Table 112. Glenmark Pharmaceuticals Pirfenidone Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 113. Glenmark Pharmaceuticals Product
Table 114. Glenmark Pharmaceuticals Recent Development
Table 115. Koye Pharmaceuticals Corporation Information
Table 116. Koye Pharmaceuticals Description and Major Businesses
Table 117. Koye Pharmaceuticals Pirfenidone Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 118. Koye Pharmaceuticals Product
Table 119. Koye Pharmaceuticals Recent Development
Table 120. MSN Laboratories Corporation Information
Table 121. MSN Laboratories Description and Major Businesses
Table 122. MSN Laboratories Pirfenidone Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. MSN Laboratories Product
Table 124. MSN Laboratories Recent Development
Table 125. Wockhardt Corporation Information
Table 126. Wockhardt Description and Major Businesses
Table 127. Wockhardt Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. Wockhardt Product
Table 129. Wockhardt Recent Development
Table 130. Incepta Pharmaceuticals Corporation Information
Table 131. Incepta Pharmaceuticals Description and Major Businesses
Table 132. Incepta Pharmaceuticals Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 133. Incepta Pharmaceuticals Product
Table 134. Incepta Pharmaceuticals Recent Development
Table 135. Unimed Unihealth Corporation Information
Table 136. Unimed Unihealth Description and Major Businesses
Table 137. Unimed Unihealth Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 138. Unimed Unihealth Product
Table 139. Unimed Unihealth Recent Development
Table 140. Global Pirfenidone Sales Forecast by Regions (2021-2026) (K Pcs)
Table 141. Global Pirfenidone Sales Market Share Forecast by Regions (2021-2026)
Table 142. Global Pirfenidone Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 143. Global Pirfenidone Revenue Market Share Forecast by Regions (2021-2026)
Table 144. North America: Pirfenidone Sales Forecast by Country (2021-2026) (K Pcs)
Table 145. North America: Pirfenidone Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Europe: Pirfenidone Sales Forecast by Country (2021-2026) (K Pcs)
Table 147. Europe: Pirfenidone Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Asia Pacific: Pirfenidone Sales Forecast by Region (2021-2026) (K Pcs)
Table 149. Asia Pacific: Pirfenidone Revenue Forecast by Region (2021-2026) (US$ Million)
Table 150. Latin America: Pirfenidone Sales Forecast by Country (2021-2026) (K Pcs)
Table 151. Latin America: Pirfenidone Revenue Forecast by Country (2021-2026) (US$ Million)
Table 152. Middle East and Africa: Pirfenidone Sales Forecast by Country (2021-2026) (K Pcs)
Table 153. Middle East and Africa: Pirfenidone Revenue Forecast by Country (2021-2026) (US$ Million)
Table 154. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 155. Key Challenges
Table 156. Market Risks
Table 157. Main Points Interviewed from Key Pirfenidone Players
Table 158. Pirfenidone Customers List
Table 159. Pirfenidone Distributors List
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
Table 1. Pirfenidone Market Segments
Table 2. Ranking of Global Top Pirfenidone Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pirfenidone Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Tablet
Table 5. Major Manufacturers of Capsule
Table 6. Major Manufacturers of Other
Table 7. COVID-19 Impact Global Market: (Four Pirfenidone Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Pirfenidone Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Pirfenidone Players to Combat Covid-19 Impact
Table 12. Global Pirfenidone Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 13. Global Pirfenidone Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 14. Global Pirfenidone Sales by Regions 2015-2020 (K Pcs)
Table 15. Global Pirfenidone Sales Market Share by Regions (2015-2020)
Table 16. Global Pirfenidone Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Pirfenidone Sales by Manufacturers (2015-2020) (K Pcs)
Table 18. Global Pirfenidone Sales Share by Manufacturers (2015-2020)
Table 19. Global Pirfenidone Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Pirfenidone by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pirfenidone as of 2019)
Table 21. Pirfenidone Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Pirfenidone Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Pirfenidone Price (2015-2020) (USD/Pcs)
Table 24. Pirfenidone Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Pirfenidone Product Type
Table 26. Date of International Manufacturers Enter into Pirfenidone Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Pirfenidone Sales by Type (2015-2020) (K Pcs)
Table 29. Global Pirfenidone Sales Share by Type (2015-2020)
Table 30. Global Pirfenidone Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Pirfenidone Revenue Share by Type (2015-2020)
Table 32. Pirfenidone Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 33. Global Pirfenidone Sales by Application (2015-2020) (K Pcs)
Table 34. Global Pirfenidone Sales Share by Application (2015-2020)
Table 35. North America Pirfenidone Sales by Country (2015-2020) (K Pcs)
Table 36. North America Pirfenidone Sales Market Share by Country (2015-2020)
Table 37. North America Pirfenidone Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Pirfenidone Revenue Market Share by Country (2015-2020)
Table 39. North America Pirfenidone Sales by Type (2015-2020) (K Pcs)
Table 40. North America Pirfenidone Sales Market Share by Type (2015-2020)
Table 41. North America Pirfenidone Sales by Application (2015-2020) (K Pcs)
Table 42. North America Pirfenidone Sales Market Share by Application (2015-2020)
Table 43. Europe Pirfenidone Sales by Country (2015-2020) (K Pcs)
Table 44. Europe Pirfenidone Sales Market Share by Country (2015-2020)
Table 45. Europe Pirfenidone Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Pirfenidone Revenue Market Share by Country (2015-2020)
Table 47. Europe Pirfenidone Sales by Type (2015-2020) (K Pcs)
Table 48. Europe Pirfenidone Sales Market Share by Type (2015-2020)
Table 49. Europe Pirfenidone Sales by Application (2015-2020) (K Pcs)
Table 50. Europe Pirfenidone Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Pirfenidone Sales by Region (2015-2020) (K Pcs)
Table 52. Asia Pacific Pirfenidone Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Pirfenidone Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Pirfenidone Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Pirfenidone Sales by Type (2015-2020) (K Pcs)
Table 56. Asia Pacific Pirfenidone Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Pirfenidone Sales by Application (2015-2020) (K Pcs)
Table 58. Asia Pacific Pirfenidone Sales Market Share by Application (2015-2020)
Table 59. Latin America Pirfenidone Sales by Country (2015-2020) (K Pcs)
Table 60. Latin America Pirfenidone Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Pirfenidone Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Pirfenidone Revenue Market Share by Country (2015-2020)
Table 63. Latin America Pirfenidone Sales by Type (2015-2020) (K Pcs)
Table 64. Latin America Pirfenidone Sales Market Share by Type (2015-2020)
Table 65. Latin America Pirfenidone Sales by Application (2015-2020) (K Pcs)
Table 66. Latin America Pirfenidone Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Pirfenidone Sales by Country (2015-2020) (K Pcs)
Table 68. Middle East and Africa Pirfenidone Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Pirfenidone Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Pirfenidone Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Pirfenidone Sales by Type (2015-2020) (K Pcs)
Table 72. Middle East and Africa Pirfenidone Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Pirfenidone Sales by Application (2015-2020) (K Pcs)
Table 74. Middle East and Africa Pirfenidone Sales Market Share by Application (2015-2020)
Table 75. Genentech (Roche) Corporation Information
Table 76. Genentech (Roche) Description and Major Businesses
Table 77. Genentech (Roche) Pirfenidone Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Genentech (Roche) Product
Table 79. Genentech (Roche) Recent Development
Table 80. Shionogi Corporation Information
Table 81. Shionogi Description and Major Businesses
Table 82. Shionogi Pirfenidone Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Shionogi Product
Table 84. Shionogi Recent Development
Table 85. GNI Group Corporation Information
Table 86. GNI Group Description and Major Businesses
Table 87. GNI Group Pirfenidone Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. GNI Group Product
Table 89. GNI Group Recent Development
Table 90. Beijing Continent Corporation Information
Table 91. Beijing Continent Description and Major Businesses
Table 92. Beijing Continent Pirfenidone Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Beijing Continent Product
Table 94. Beijing Continent Recent Development
Table 95. Cipla Corporation Information
Table 96. Cipla Description and Major Businesses
Table 97. Cipla Pirfenidone Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Cipla Product
Table 99. Cipla Recent Development
Table 100. Lupin Ltd Corporation Information
Table 101. Lupin Ltd Description and Major Businesses
Table 102. Lupin Ltd Pirfenidone Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Lupin Ltd Product
Table 104. Lupin Ltd Recent Development
Table 105. Zydus Cadila Corporation Information
Table 106. Zydus Cadila Description and Major Businesses
Table 107. Zydus Cadila Pirfenidone Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Zydus Cadila Product
Table 109. Zydus Cadila Recent Development
Table 110. Glenmark Pharmaceuticals Corporation Information
Table 111. Glenmark Pharmaceuticals Description and Major Businesses
Table 112. Glenmark Pharmaceuticals Pirfenidone Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 113. Glenmark Pharmaceuticals Product
Table 114. Glenmark Pharmaceuticals Recent Development
Table 115. Koye Pharmaceuticals Corporation Information
Table 116. Koye Pharmaceuticals Description and Major Businesses
Table 117. Koye Pharmaceuticals Pirfenidone Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 118. Koye Pharmaceuticals Product
Table 119. Koye Pharmaceuticals Recent Development
Table 120. MSN Laboratories Corporation Information
Table 121. MSN Laboratories Description and Major Businesses
Table 122. MSN Laboratories Pirfenidone Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. MSN Laboratories Product
Table 124. MSN Laboratories Recent Development
Table 125. Wockhardt Corporation Information
Table 126. Wockhardt Description and Major Businesses
Table 127. Wockhardt Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. Wockhardt Product
Table 129. Wockhardt Recent Development
Table 130. Incepta Pharmaceuticals Corporation Information
Table 131. Incepta Pharmaceuticals Description and Major Businesses
Table 132. Incepta Pharmaceuticals Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 133. Incepta Pharmaceuticals Product
Table 134. Incepta Pharmaceuticals Recent Development
Table 135. Unimed Unihealth Corporation Information
Table 136. Unimed Unihealth Description and Major Businesses
Table 137. Unimed Unihealth Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 138. Unimed Unihealth Product
Table 139. Unimed Unihealth Recent Development
Table 140. Global Pirfenidone Sales Forecast by Regions (2021-2026) (K Pcs)
Table 141. Global Pirfenidone Sales Market Share Forecast by Regions (2021-2026)
Table 142. Global Pirfenidone Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 143. Global Pirfenidone Revenue Market Share Forecast by Regions (2021-2026)
Table 144. North America: Pirfenidone Sales Forecast by Country (2021-2026) (K Pcs)
Table 145. North America: Pirfenidone Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Europe: Pirfenidone Sales Forecast by Country (2021-2026) (K Pcs)
Table 147. Europe: Pirfenidone Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Asia Pacific: Pirfenidone Sales Forecast by Region (2021-2026) (K Pcs)
Table 149. Asia Pacific: Pirfenidone Revenue Forecast by Region (2021-2026) (US$ Million)
Table 150. Latin America: Pirfenidone Sales Forecast by Country (2021-2026) (K Pcs)
Table 151. Latin America: Pirfenidone Revenue Forecast by Country (2021-2026) (US$ Million)
Table 152. Middle East and Africa: Pirfenidone Sales Forecast by Country (2021-2026) (K Pcs)
Table 153. Middle East and Africa: Pirfenidone Revenue Forecast by Country (2021-2026) (US$ Million)
Table 154. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 155. Key Challenges
Table 156. Market Risks
Table 157. Main Points Interviewed from Key Pirfenidone Players
Table 158. Pirfenidone Customers List
Table 159. Pirfenidone Distributors List
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Pirfenidone Product Picture
Figure 2. Global Pirfenidone Sales Market Share by Type in 2020 & 2026
Figure 3. Tablet Product Picture
Figure 4. Capsule Product Picture
Figure 5. Other Product Picture
Figure 6. Global Pirfenidone Sales Market Share by Application in 2020 & 2026
Figure 7. Mild Idiopathic Pulmonary Fibrosis
Figure 8. Moderate Idiopathic Pulmonary Fibrosis
Figure 9. Other
Figure 10. Pirfenidone Report Years Considered
Figure 11. Global Pirfenidone Market Size 2015-2026 (US$ Million)
Figure 12. Global Pirfenidone Sales 2015-2026 (K Pcs)
Figure 13. Global Pirfenidone Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Pirfenidone Sales Market Share by Region (2015-2020)
Figure 15. Global Pirfenidone Sales Market Share by Region in 2019
Figure 16. Global Pirfenidone Revenue Market Share by Region (2015-2020)
Figure 17. Global Pirfenidone Revenue Market Share by Region in 2019
Figure 18. Global Pirfenidone Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Pirfenidone Revenue in 2019
Figure 20. Pirfenidone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Pirfenidone Sales Market Share by Type (2015-2020)
Figure 22. Global Pirfenidone Sales Market Share by Type in 2019
Figure 23. Global Pirfenidone Revenue Market Share by Type (2015-2020)
Figure 24. Global Pirfenidone Revenue Market Share by Type in 2019
Figure 25. Global Pirfenidone Market Share by Price Range (2015-2020)
Figure 26. Global Pirfenidone Sales Market Share by Application (2015-2020)
Figure 27. Global Pirfenidone Sales Market Share by Application in 2019
Figure 28. Global Pirfenidone Revenue Market Share by Application (2015-2020)
Figure 29. Global Pirfenidone Revenue Market Share by Application in 2019
Figure 30. North America Pirfenidone Sales Growth Rate 2015-2020 (K Pcs)
Figure 31. North America Pirfenidone Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Pirfenidone Sales Market Share by Country in 2019
Figure 33. North America Pirfenidone Revenue Market Share by Country in 2019
Figure 34. U.S. Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 35. U.S. Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. Canada Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Pirfenidone Market Share by Type in 2019
Figure 39. North America Pirfenidone Market Share by Application in 2019
Figure 40. Europe Pirfenidone Sales Growth Rate 2015-2020 (K Pcs)
Figure 41. Europe Pirfenidone Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Pirfenidone Sales Market Share by Country in 2019
Figure 43. Europe Pirfenidone Revenue Market Share by Country in 2019
Figure 44. Germany Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 45. Germany Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. France Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. U.K. Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. Italy Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Russia Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Pirfenidone Market Share by Type in 2019
Figure 55. Europe Pirfenidone Market Share by Application in 2019
Figure 56. Asia Pacific Pirfenidone Sales Growth Rate 2015-2020 (K Pcs)
Figure 57. Asia Pacific Pirfenidone Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Pirfenidone Sales Market Share by Region in 2019
Figure 59. Asia Pacific Pirfenidone Revenue Market Share by Region in 2019
Figure 60. China Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. China Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. Japan Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. South Korea Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. India Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. Australia Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Taiwan Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Indonesia Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Thailand Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Malaysia Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Philippines Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Vietnam Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Pirfenidone Market Share by Type in 2019
Figure 83. Asia Pacific Pirfenidone Market Share by Application in 2019
Figure 84. Latin America Pirfenidone Sales Growth Rate 2015-2020 (K Pcs)
Figure 85. Latin America Pirfenidone Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Pirfenidone Sales Market Share by Country in 2019
Figure 87. Latin America Pirfenidone Revenue Market Share by Country in 2019
Figure 88. Mexico Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 89. Mexico Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Brazil Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Argentina Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Pirfenidone Market Share by Type in 2019
Figure 95. Latin America Pirfenidone Market Share by Application in 2019
Figure 96. Middle East and Africa Pirfenidone Sales Growth Rate 2015-2020 (K Pcs)
Figure 97. Middle East and Africa Pirfenidone Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Pirfenidone Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Pirfenidone Revenue Market Share by Country in 2019
Figure 100. Turkey Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 101. Turkey Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Saudi Arabia Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. U.A.E Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Pirfenidone Market Share by Type in 2019
Figure 107. Middle East and Africa Pirfenidone Market Share by Application in 2019
Figure 108. Genentech (Roche) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Shionogi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. GNI Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Beijing Continent Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Lupin Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Zydus Cadila Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Glenmark Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Koye Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. MSN Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Wockhardt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Incepta Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Unimed Unihealth Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. North America Pirfenidone Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 122. North America Pirfenidone Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Europe Pirfenidone Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 124. Europe Pirfenidone Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Asia Pacific Pirfenidone Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 126. Asia Pacific Pirfenidone Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Latin America Pirfenidone Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 128. Latin America Pirfenidone Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Middle East and Africa Pirfenidone Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 130. Middle East and Africa Pirfenidone Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Porter's Five Forces Analysis
Figure 132. Channels of Distribution
Figure 133. Distributors Profiles
Figure 134. Bottom-up and Top-down Approaches for This Report
Figure 135. Data Triangulation
Figure 136. Key Executives Interviewed
Figure 1. Pirfenidone Product Picture
Figure 2. Global Pirfenidone Sales Market Share by Type in 2020 & 2026
Figure 3. Tablet Product Picture
Figure 4. Capsule Product Picture
Figure 5. Other Product Picture
Figure 6. Global Pirfenidone Sales Market Share by Application in 2020 & 2026
Figure 7. Mild Idiopathic Pulmonary Fibrosis
Figure 8. Moderate Idiopathic Pulmonary Fibrosis
Figure 9. Other
Figure 10. Pirfenidone Report Years Considered
Figure 11. Global Pirfenidone Market Size 2015-2026 (US$ Million)
Figure 12. Global Pirfenidone Sales 2015-2026 (K Pcs)
Figure 13. Global Pirfenidone Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Pirfenidone Sales Market Share by Region (2015-2020)
Figure 15. Global Pirfenidone Sales Market Share by Region in 2019
Figure 16. Global Pirfenidone Revenue Market Share by Region (2015-2020)
Figure 17. Global Pirfenidone Revenue Market Share by Region in 2019
Figure 18. Global Pirfenidone Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Pirfenidone Revenue in 2019
Figure 20. Pirfenidone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Pirfenidone Sales Market Share by Type (2015-2020)
Figure 22. Global Pirfenidone Sales Market Share by Type in 2019
Figure 23. Global Pirfenidone Revenue Market Share by Type (2015-2020)
Figure 24. Global Pirfenidone Revenue Market Share by Type in 2019
Figure 25. Global Pirfenidone Market Share by Price Range (2015-2020)
Figure 26. Global Pirfenidone Sales Market Share by Application (2015-2020)
Figure 27. Global Pirfenidone Sales Market Share by Application in 2019
Figure 28. Global Pirfenidone Revenue Market Share by Application (2015-2020)
Figure 29. Global Pirfenidone Revenue Market Share by Application in 2019
Figure 30. North America Pirfenidone Sales Growth Rate 2015-2020 (K Pcs)
Figure 31. North America Pirfenidone Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Pirfenidone Sales Market Share by Country in 2019
Figure 33. North America Pirfenidone Revenue Market Share by Country in 2019
Figure 34. U.S. Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 35. U.S. Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. Canada Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Pirfenidone Market Share by Type in 2019
Figure 39. North America Pirfenidone Market Share by Application in 2019
Figure 40. Europe Pirfenidone Sales Growth Rate 2015-2020 (K Pcs)
Figure 41. Europe Pirfenidone Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Pirfenidone Sales Market Share by Country in 2019
Figure 43. Europe Pirfenidone Revenue Market Share by Country in 2019
Figure 44. Germany Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 45. Germany Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. France Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. U.K. Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. Italy Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Russia Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Pirfenidone Market Share by Type in 2019
Figure 55. Europe Pirfenidone Market Share by Application in 2019
Figure 56. Asia Pacific Pirfenidone Sales Growth Rate 2015-2020 (K Pcs)
Figure 57. Asia Pacific Pirfenidone Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Pirfenidone Sales Market Share by Region in 2019
Figure 59. Asia Pacific Pirfenidone Revenue Market Share by Region in 2019
Figure 60. China Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. China Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. Japan Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. South Korea Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. India Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. Australia Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Taiwan Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Indonesia Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Thailand Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Malaysia Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Philippines Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Vietnam Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Pirfenidone Market Share by Type in 2019
Figure 83. Asia Pacific Pirfenidone Market Share by Application in 2019
Figure 84. Latin America Pirfenidone Sales Growth Rate 2015-2020 (K Pcs)
Figure 85. Latin America Pirfenidone Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Pirfenidone Sales Market Share by Country in 2019
Figure 87. Latin America Pirfenidone Revenue Market Share by Country in 2019
Figure 88. Mexico Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 89. Mexico Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Brazil Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Argentina Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Pirfenidone Market Share by Type in 2019
Figure 95. Latin America Pirfenidone Market Share by Application in 2019
Figure 96. Middle East and Africa Pirfenidone Sales Growth Rate 2015-2020 (K Pcs)
Figure 97. Middle East and Africa Pirfenidone Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Pirfenidone Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Pirfenidone Revenue Market Share by Country in 2019
Figure 100. Turkey Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 101. Turkey Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Saudi Arabia Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Pirfenidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. U.A.E Pirfenidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Pirfenidone Market Share by Type in 2019
Figure 107. Middle East and Africa Pirfenidone Market Share by Application in 2019
Figure 108. Genentech (Roche) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Shionogi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. GNI Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Beijing Continent Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Lupin Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Zydus Cadila Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Glenmark Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Koye Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. MSN Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Wockhardt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Incepta Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Unimed Unihealth Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. North America Pirfenidone Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 122. North America Pirfenidone Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Europe Pirfenidone Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 124. Europe Pirfenidone Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Asia Pacific Pirfenidone Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 126. Asia Pacific Pirfenidone Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Latin America Pirfenidone Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 128. Latin America Pirfenidone Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Middle East and Africa Pirfenidone Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 130. Middle East and Africa Pirfenidone Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Porter's Five Forces Analysis
Figure 132. Channels of Distribution
Figure 133. Distributors Profiles
Figure 134. Bottom-up and Top-down Approaches for This Report
Figure 135. Data Triangulation
Figure 136. Key Executives Interviewed
